Real-time enrollment status for this severe hypertriglyceridemia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:38 AM UTC
| NCT Number | NCT06880770 |
| Recruiting Status | Recruiting |
| Condition | Severe Hypertriglyceridemia |
| Phase | PHASE3 |
| Target Enrollment | 288 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Arrowhead Pharmaceuticals |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT06880770 is currently recruiting participants. This phase3 study for severe hypertriglyceridemia is actively seeking new participants at 16 locations across the United States. The study is sponsored by Arrowhead Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06880770 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06880770 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.